Bioassociate Consulting
Long/short equity, value, event-driven, long only

Bioassociate Initiated Coverage On Oramed Pharmaceuticals With A Buy

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) is a public biotechnology company based in Jerusalem, Israel. Oramed develops an orally ingestible capsule for the delivery of protein-based therapies to the blood circulation through the gastro-intestinal (NYSE:GI) pathway, with focus on treatment of diabetes. The Company's business model is based on advancing in-house R&D projects, based on its proprietary drug delivery system, up to mid-stage clinical development, following which the company will aspire to sublicense specific products to major players in the pharmaceutical marketplace.

The company's stock was traded in the OTCQB market until Feb 8, 2013. On Jan 22, 2013, Oramed announced a one for twelve reverse stock split in order to help it meet the qualifications for listing

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details